首页> 外文OA文献 >Effect of osteoporotic fractures on overall survival in patients with non-metastatic prostatic cancer having androgen deprivation therapy

【2h】

Effect of osteoporotic fractures on overall survival in patients with non-metastatic prostatic cancer having androgen deprivation therapy

机译：骨质疏松性骨折对雄激素剥夺治疗非转移性前列腺癌患者总体生存率的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This journal suppl. is Special Issue: Abstracts of the 11th Asian Congress of Urology of the Urological Association of Asia, Thailand 2012

机译：该杂志补充。是特刊：2012年泰国亚洲泌尿外科学会第十一届亚洲泌尿外科大会摘要

著录项

作者
Lai, TCT; Ho, KL; Wong, JKW; Tsang, CF; Wong, EMH; Wong, SCW; Yiu, MK;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial [J] . Shinde Ashwin, Li Richard, Amini Arya, European urology . 2019,第3期

机译：Re：Liselotte Ms Boeve，Maarten CCM Hulshof，Andre N. Vis等人。与雄激素剥夺治疗相比，对雄激素剥夺治疗的生存对雄激素剥夺治疗与前瞻性随机临床试验中原发性骨转移前列腺癌前列腺患者的同时剥夺治疗的影响：来自血腥审判的数据。 EUR UROL 2019; 75：410-8转移性前列腺癌中的明确治疗的未来步骤：来自血轮试验的教训
2. Re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8 [J] . Andres Garcia-Perdomo Herney European urology . 2019,第4期

机译：Re：Liselotte Ms Boeve，Maarten CCM Hulshof，Andre N. Vis等人。与雄激素剥夺治疗相比，对雄激素剥夺治疗的生存对雄激素剥夺治疗与前瞻性随机临床试验中原发性骨转移前列腺癌前列腺患者的同时剥夺治疗的影响：来自血腥审判的数据。 EUR UROL 2019; 75：410-8
3. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial [J] . Boeve Liselotte M. S., Hulshof Maarten C. C. M., Vis Andre N., European urology . 2019,第3期

机译：与雄激素剥夺治疗相比，与雄激素剥夺治疗相结合的雄激素剥夺治疗与前瞻性临床试验中原发性骨转移前列腺癌患者的前列腺患者的生存对雄激素剥夺治疗的生存：来自血腥审判的数据
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Cost and Management of Fractures in Medicare Beneficiaries with Non-Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy. [D] . Yong, Candice Yuk Chen. 2015

机译：用雄激素剥夺疗法治疗的非转移性前列腺癌医疗保险受益人骨折的成本和管理。
6. Clinical Risk Factors for Osteoporotic Fractures in Men With Non-Metastatic Prostate Cancer on Androgen Deprivation Therapy With or Without Anti-Osteoporosis Treatment [O] . Hajerah Sonnabend, Vishnu Priya Pulipati, Sanford Baim, 2021

机译：非转移前列腺癌骨质疏松骨折对雄激素剥夺治疗的骨质疏松骨折的临床危险因素抗骨质疏松症治疗
7. 223P Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC) [O] . K. Fizazi, N.D. Shore, T.L.J. Tammela, 2020

机译：223P整体存活（OS）III阶段Aramis研究Darolutamide（Daro）的研究，添加到雄激素剥夺治疗（ADT）进行非转移性阉割前列腺癌（NMCRPC）
8. Hot Flashes among Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Psychosocial and Quality of Life Issues [R] . Coyne, J. , Vaughn, D. J. , Dinges, D. , 2006

机译：接受雄激素剥夺治疗的前列腺癌患者的热潮：心理社会和生活质量问题

Effect of osteoporotic fractures on overall survival in patients with non-metastatic prostatic cancer having androgen deprivation therapy

摘要

著录项

相似文献

相关主题

期刊订阅